NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection
暂无分享,去创建一个
[1] C. Brander,et al. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. , 2013, Journal of hepatology.
[2] G. Reynolds,et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion , 2013, The Journal of experimental medicine.
[3] C. Rolny,et al. Activated monocytes augment TRAIL‐mediated cytotoxicity by human NK cells through release of IFN‐γ , 2013, European journal of immunology.
[4] Meijuan Huang,et al. Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell–mediated fulminant hepatitis in mice , 2013, Hepatology.
[5] W. Rosenberg,et al. Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection , 2012, PloS one.
[6] P. Lampertico,et al. IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection , 2012, The Journal of Immunology.
[7] M. Odenthal,et al. TNF-induced target cell killing by CTL activated through cross-presentation. , 2012, Cell reports.
[8] M. Imamura,et al. Severe necroinflammatory reaction caused by natural killer cell‐mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse , 2012, Hepatology.
[9] J. Nattermann,et al. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner , 2012, Laboratory Investigation.
[10] Binqing Fu,et al. TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence , 2012, PLoS pathogens.
[11] Percy A. Knolle,et al. Living in the liver: hepatic infections , 2012, Nature Reviews Immunology.
[12] M. Takamura,et al. Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence. , 2012, Journal of hepatology.
[13] A. Boonstra,et al. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells , 2012, Journal of viral hepatitis.
[14] T. Mak,et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity , 2011, Proceedings of the National Academy of Sciences.
[15] R. Welsh,et al. Natural killer cells act as rheostats modulating antiviral T cells , 2011, Nature.
[16] G. Kazemier,et al. NK cells can generate from precursors in the adult human liver , 2011, European journal of immunology.
[17] T. Liang,et al. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. , 2011, Gastroenterology.
[18] F. Shi,et al. Organ-specific features of natural killer cells , 2011, Nature Reviews Immunology.
[19] Todd M. Allen,et al. HIV-1 adaptation to NK cell mediated immune pressure , 2011, Nature.
[20] H. Janssen,et al. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. , 2011, Journal of hepatology.
[21] Jiyuan Zhang,et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients , 2011, Hepatology.
[22] Michael Ederer,et al. Tumor necrosis factor α sensitizes primary murine hepatocytes to Fas/CD95‐induced apoptosis in a Bim‐ and Bid‐dependent manner , 2011, Hepatology.
[23] M. Maini,et al. Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection , 2010, PLoS pathogens.
[24] A. Telenti,et al. Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses , 2010, Nature Immunology.
[25] R. Welsh,et al. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. , 2010, The Journal of clinical investigation.
[26] Hans-Gustaf Ljunggren,et al. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. , 2010, Gastroenterology.
[27] Michael G Brown,et al. Intrahepatic IL-10 Maintains NKG2A+Ly49− Liver NK Cells in a Functionally Hyporesponsive State , 2010, The Journal of Immunology.
[28] Y. Liu,et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. , 2010, Journal of hepatology.
[29] Q. Ning,et al. Increased Killing of Liver NK Cells by Fas/Fas Ligand and NKG2D/NKG2D Ligand Contributes to Hepatocyte Necrosis in Virus-Induced Liver Failure , 2009, The Journal of Immunology.
[30] P. Klenerman,et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.
[31] G. Michelone,et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.
[32] C. Trautwein,et al. Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage , 2009, The Journal of experimental medicine.
[33] G. Plitas,et al. The Lytic Potential of Human Liver NK Cells Is Restricted by Their Limited Expression of Inhibitory Killer Ig-Like Receptors1 , 2009, The Journal of Immunology.
[34] I. N. Crispe,et al. The liver as a lymphoid organ. , 2009, Annual review of immunology.
[35] B. Stockinger. Immunology: Cause of death matters , 2009, Nature.
[36] M. Massari,et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection , 2009, Gut.
[37] N. D. Churchill,et al. Churchill and Tomasz I. Michalak Hepadnavirus during Acute Infection with Woodchuck Responses Immediately after Invasion and with Innate and Adaptive Immune Intrahepatic Expression of Genes Affiliated , 2022 .
[38] G. Gores,et al. Cellular and molecular mechanisms of liver injury. , 2008, Gastroenterology.
[39] G. Dusheiko,et al. Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. , 2008, The Lancet. Infectious diseases.
[40] R. Pierce,et al. TLR-dependent cross talk between human Kupffer cells and NK cells , 2008, The Journal of experimental medicine.
[41] William H. Carr,et al. Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes , 2007, The Journal of experimental medicine.
[42] A. Murphy,et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. , 2007, Immunity.
[43] R. Sun,et al. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D‐ligand interaction and natural killer cells , 2007, Hepatology.
[44] C. Biron,et al. Keeping NK cells in highly regulated antiviral warfare. , 2007, Trends in immunology.
[45] P. Borrow,et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage , 2007, The Journal of experimental medicine.
[46] Lifen Gao,et al. Hepatitis B Virus Sensitizes Hepatocytes to TRAIL-Induced Apoptosis through Bax1 , 2007, The Journal of Immunology.
[47] H. Janssen,et al. Different composition of intrahepatic lymphocytes in the immune‐tolerance and immune‐clearance phase of chronic hepatitis B , 2006, Journal of medical virology.
[48] K. Arihiro,et al. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans , 2006, Hepatology.
[49] R. Sun,et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.
[50] K. Shiraki,et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. , 2005, Human pathology.
[51] Salim I. Khakoo,et al. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.
[52] G. Gores,et al. Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. , 2003, Journal of hepatology.
[53] R. Purcell,et al. CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.
[54] J. Orange,et al. Viral evasion of natural killer cells , 2002, Nature Immunology.
[55] F. Chisari,et al. Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[56] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[57] F. Chisari,et al. Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes , 2001, The Journal of experimental medicine.
[58] H. Pircher,et al. Concerted Action of the FasL/Fas and Perforin/Granzyme A and B Pathways Is Mandatory for the Development of Early Viral Hepatitis but Not for Recovery from Viral Infection , 2001, Journal of Virology.
[59] D. Thiele,et al. Virally Infected Hepatocytes Are Resistant to Perforin-Dependent CTL Effector Mechanisms1 , 2001, The Journal of Immunology.
[60] D. Vergani,et al. Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.
[61] F. Chisari,et al. Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo , 2000, The Journal of experimental medicine.
[62] Antonio Bertoletti,et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. , 2000 .
[63] D. Doherty,et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. , 1999, Journal of immunology.
[64] M. Shapiro,et al. Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.
[65] V. Barnaba,et al. Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis , 1998, European journal of immunology.
[66] J. Orange,et al. Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent Pathways , 1998, The Journal of experimental medicine.
[67] R. Welsh,et al. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells , 1997, Journal of virology.
[68] A. Meager,et al. Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. , 1996, The American journal of gastroenterology.
[69] P. Galle,et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.
[70] E. O’Neill,et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.
[71] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[72] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[73] R. Michael. B Virus Infection , 1966 .
[74] A. Telenti,et al. Critical role for the chemokine receptor CXCR 6 in NK cell – mediated antigen-specific memory of haptens and viruses , 2010 .
[75] G. Plitas,et al. Inhibitory Killer Ig-Like Receptors Is Restricted by Their Limited Expression of The Lytic Potential of Human Liver NK Cells , 2009 .
[76] Zhang Hong-quan. A new potential target of asthma therapy:T cell immunoglobulin-and mucin-domain-containing molecule-3 , 2007 .
[77] YOUHAI H. Chen,et al. Critical roles of TRAIL in hepatic cell death and hepatic inflammation. , 2004, The Journal of clinical investigation.
[78] R. Purcell,et al. CD 8 T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection † , 2002 .
[79] M. Smyth,et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.
[80] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.